Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Epigenetics|March 11, 2008
HDACs and HDAC inhibitors in colon cancerJohn M Mariadason
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 7, 2004
Customizing chemotherapy for colon cancer: the potential of gene expression profilingJohn M Mariadason, Diego Arango, Leonard H Augenlicht
Hematology/Oncology Clinics of North America|May 10, 2003
Microarray analysis in the clinical management of cancerJohn M Mariadason, Leonard H Augenlicht, Diego Arango
Molecules (Basel, Switzerland)|September 12, 2018
ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and CancerIan Y Luk, Camilla M Reehorst, John M Mariadason
Current Cancer Drug Targets|August 20, 2010
Strategies for overcoming inherent and acquired resistance to EGFR inhibitors by targeting downstream effectors in the RAS/PI3K pathwayAndrew J Weickhardt, Niall C Tebbutt, John M Mariadason
Biomedicines|May 25, 2024
Clinical Developments and Challenges in Treating FGFR2-Driven Gastric CancerDavid K Lau, Jack P Collin, John M Mariadason
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2018
Cell Line Models of Molecular Subtypes of Colorectal CancerJennifer K Mooi, Ian Y Luk, John M Mariadason
Frontiers in Oncology|February 21, 2015
Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancerLloyd Pereira, John M Mariadason, Ross D Hannan, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|April 3, 2025
Connecting concentrations of copper, selenium, and zinc with transcriptomic and proteomic data of well-characterized human colorectal cancer cell linesCaroline E Meyer, Natalia Vukelic, John M Mariadason, et al.
Trends in Cancer|September 30, 2017
Aberrant DNA Methylation in Colorectal Cancer: What Should We Target?Janson W T Tse, Laura J Jenkins, Fiona Chionh, et al.
Pageof 12